Position
GERBER, LLC in Monopar Therapeutics
Back to the book · All holders of MNPR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$58.9K$65.30 → $54.79
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 5.6K | $365.7K | — | — | — | 0.2% |
| Q1 2026 | 5.6K | $306.9K | $54.79 | −$58.9K | $0 | 0.2% |